1. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial. (January 2022) Authors: Mariette, Xavier; Hermine, Olivier; Tharaux, Pierre-Louis; Resche-Rigon, Matthieu; Porcher, Raphael; Ravaud, Philippe; Bureau, Serge; Dougados, Maxime; Tibi, Annick; Azoulay, Elie; Cadranel, Jacques; Emmerich, Joseph; Fartoukh, Muriel; Guidet, Bertrand; Humbert, Marc; Lacombe, Karine; Mahevas, Ma... Journal: Lancet Issue: Volume 4:Number 1(2022) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗